You have 9 free searches left this month | to do more
Showing 1 - 25 of
1,786 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
H
Active, not recruiting
  • Small Cell Lung Cancer
  • ETOPOSIDE - Usual
  • ETOPOSIDE - Study
  • North Bethesda, Maryland
    Medicine Invention Design, Inc. (MIDI) - IORG0007849
2021-08-30
Aug 30, 2021
B
Active, not recruiting
  • COVID-19
  • Etoposide
  • Boston, Massachusetts
    Boston Medical Center
2022-01-07
Jan 7, 2022
A
Not yet recruiting
  • Glioblastoma Multiforme
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
2021-07-22
Jul 22, 2021
C
Recruiting
  • Triple Negative Breast Cancer
  • oral etoposide + anlotinib
  • Beijing, China
    Cancer Institute & Hospital. Chinese Academy of Medical Sciences
2021-07-15
Jul 15, 2021
L
Recruiting
  • Extensive-stage Small-cell Lung Cancer
  • ZKAB001
  • +3 more
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
2021-09-08
Sep 8, 2021
M
Active, not recruiting
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-09-22
Sep 22, 2021
U
Active, not recruiting
  • Leukemia
  • +2 more
  • Gainesville, Florida
    UF Health Shands Cancer Hospital
2021-10-28
Oct 28, 2021
N
Recruiting
  • Germ Cell Tumor
  • +2 more
  • Etoposide
  • Indianapolis, Indiana
    Indiana University Melvin & Bren Simon Cancer Center
2021-08-23
Aug 23, 2021
P
Active, not recruiting
  • Effect of Drug
  • +2 more
  • Apatinib Mesylate
  • ifosfamide and etoposide
  • Beijing, Beijing, China
    Peking University People's Hospital
2021-03-28
Mar 28, 2021
B
Active, not recruiting
  • Small Cell Lung Cancer
  • Barcelona, Spain
  • +3 more
2021-11-08
Nov 8, 2021
S
Recruiting
  • Treatment Refusal
  • Guangzhou, Please Select, China
    Sun Yat-sen University Cancer Center
2020-12-16
Dec 16, 2020
S
Active, not recruiting
  • Non-Hodgkin's Lymphoma
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
2021-06-03
Jun 3, 2021
B
Recruiting
  • Recurrent Medulloblastoma
  • Apatinib Combined With Temozolomide and Etoposide Capsules
  • Beijing, China
    Beijing Sanbo Brain Hospital
2021-03-14
Mar 14, 2021
T
Recruiting
  • Brain Tumor Recurrent
  • Houston, Texas
    UTHealth & Children's Memorial Hermann Hospital
2021-10-27
Oct 27, 2021
C
Completed
  • Breast Cancer
  • apatinib+oral etoposide
  • Beijing, Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
2020-12-01
Dec 1, 2020
C
Not yet recruiting
  • Small-cell Lung Cancer
  • (no location specified)
2020-12-23
Dec 23, 2020
S
Unknown status
  • SCLC
  • Anlotinib
  • Anlotinib hydrochloride
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Chest hospital
2020-12-22
Dec 22, 2020
S
Completed
  • Ovarian Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
2020-12-03
Dec 3, 2020
P
Recruiting
  • Neuroendocrine Tumors
  • Neuroendocrine Carcinoma
  • Beijing, Beijing, China
  • +2 more
2021-11-02
Nov 2, 2021
N
Completed
  • Peripheral T-cell Lymphoma
  • Singapore, Singapore
    National Cancer Centre Singapore
2021-04-27
Apr 27, 2021
K
Recruiting
  • Acute Myeloid Leukemia
  • mitoxantrone + etoposide + gemtuzumab ozogamicin
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
2021-02-01
Feb 1, 2021
F
Recruiting
  • Lung Neoplasm
  • +2 more
  • Camrelizumab combined with Apatinib, Etoposide and Cisplatin
  • Fuzhou, Fujian, China
    The 900th Hospital of Joint Logistic Support Force
2021-02-03
Feb 3, 2021
S
Recruiting
  • Acute Lymphoblastic Leukemia
  • Seoul, Daehangno, Jongno-gu, Korea, Republic of
    Seoul National University Hospital
2021-06-15
Jun 15, 2021